Looking Ahead, States Begin Casting Biosimilar Safety Net
By Mari Serebrov
Washington Editor
Washington Editor
Monday, January 28, 2013
While the FDA is still waiting for its first biosimilar application to be submitted, a few states with the encouragement of patient advocacy groups and the biopharma industry are already casting a safety net for when interchangeable biologics hit the U.S. market.
To continue reading subscribe now to Latest News
Learn More about Latest News
Already a subscriber? Sign In or Buy now to activate your subscription
Note: our contact information has changed
Customer Care: http://support.clarivate.com
© 2018 Clarivate Analytics.
Reproduction, reposting content is strictly prohibited.
Reproduction, reposting content is strictly prohibited.